| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ICCC sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 205.7K | $1.20M | - | |
| CEO | 17.8K | $168.9K | - | |
| Dir | 4.7K | $22.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2017 | Pessin Brian L. | See Explanation of Responses | Buy | 30,000 | $5.25 | $157,500.00 | +75.0% | |
| Mar 14, 2017 | Tomsche David Scott | Director | Buy | 2,000 | $5.43 | $10,861.44 | +2.8% | |
| Nov 7, 2016 | Tomsche David Scott | Director | Buy | 4,000 | $5.19 | $20,760.00 | +6.0% | |
| Aug 22, 2016 | Cunningham David | Director | Buy | 3,000 | $7.14 | $21,430.80 | +46.8% | |
| Jul 8, 2016 | Crabb Joseph H | VP &Chief Scientific Officer | Sell | 1,935 | $6.55 | $12,669.19 | -1.8% | |
| Jul 7, 2016 | Crabb Joseph H | VP &Chief Scientific Officer | Sell | 2,691 | $6.58 | $17,711.34 | -2.5% | |
| Jul 5, 2016 | Crabb Joseph H | Vice President and CSO | Sell | 5,374 | $6.74 | $36,200.51 | -4.7% | |
| Mar 21, 2016 | Tomsche David Scott | Director | Buy | 955 | $6.67 | $6,369.85 | +1.5% | |
| Jan 29, 2016 | Rothschild Jonathan E | Director, 10% Owner | Buy | 9,522 | $5.25 | $49,990.50 | +1.9% | |
| Jan 29, 2016 | Cunningham David | Director | Buy | 1,904 | $5.25 | $9,996.00 | +34.6% |